Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Chronos Therapeutics Announces Positive Pre-clinical Proof of Concept in MS Fatigue Model

Chronos Therapeutics Announces Positive Pre-clinical Proof of Concept in MS Fatigue Model. Patents for the Fatigue programme awarded in USA and Europe. 

Read the rest of entry »

PCI Clinical Services to Showcase Expertise in Phase I Clinical Trials in Australia

Philadelphia, USA – December 3, 2018 PCI Pharma Services (PCI), full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commercial packaging to the global biopharmaceutical industry, will showcase its expertise in Phase I Clinical Trials in Australia with a series of West Coast US seminars in January 2019. 

Read the rest of entry »

The UK’s first dedicated Vaccines Manufacturing Innovation Centre to be located at The Oxford Science Park

The UK’s first dedicated Vaccines Manufacturing Innovation Centre (VMIC) will be located at The Oxford Science Park (TOSP), one of the UK's leading parks for science and technology companies, it was announced today

Read the rest of entry »

Changes in Leadership at BioCity Group

BioCity Group has today announced that its founding CEO, Dr Glenn Crocker, MBE, will be stepping down at the end of the year and taking up the role of Chairman.

Read the rest of entry »

Synpromics named among the top 50 fastest growing technology companies in the UK

Synpromics, the leader in gene control, is delighted to announce that it has been ranked 12th in the Deloitte ‘UK Technology Fast 50’ at the annual awards ceremony in London.

Read the rest of entry »

Immunocore and Genentech Expand Partnership to Develop Cancer Immunotherapy MEDICAL

Immunocore and the US biotech giant Genentech are building on their existing partnership to boost the clinical development of Immunocore’s immunotherapy for treating solid tumors.

Read the rest of entry »

Leading recruitment agency assembles new Operations Team to spearhead its ‘next generation flexible work model’

SRG, the leading science, clinical and engineering recruitment agency, is today announcing a new operational leadership team for Synergy, its flexible science insourcing service dubbed the ‘next generation flexible work model’. 

Read the rest of entry »

Induced Pluripotent Stem Cells for Regenerative Research

AMSBIO announces that induced pluripotent stem (iPS) cell expert - Dr Masato Nakagawa from the Nobel Prize winning Yamanaka Lab** at the Centre for iPS Cell Research and Application, Kyoto University, Japan will give 3 talks in the UK on the 10th and 11th December 2018.

Read the rest of entry »

AMSBIO Expand Range of FFPE Cancer Cell Line Controls

AMSBIO has expanded its range of high quality FFPE cancer cell line controls for immunohistochemistry (IHC), in situ hybridization (ISH) and Next Generation Sequencing (NGS) applications.
 

Read the rest of entry »

Evox Therapeutics has secured £655,000 in funding from Duchenne UK

Evox Therapeutics has secured £655,000 in funding from Duchenne UK, to support exploration of its exosome-based therapeutic platform for the condition.Duchenne is a highly debilitating, progressive, muscle-wasting disorder caused by the lack of functional dystrophin protein, for which there is currently no cure.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.